Cochlear implant study aims to Fine-Tune hearing recovery for all ages

NCT ID NCT07380269

First seen Feb 02, 2026 · Last updated Jun 21, 2026 · Updated 20 times

Summary

This study follows 300 deaf patients of all ages who receive cochlear implants, tracking their hearing, speech, and quality of life over time. Researchers aim to see how different age groups and treatment types respond, to personalize rehabilitation. Participants must have severe hearing loss and speak Mandarin Chinese.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Eye & ENT Hospital of Fudan University

    RECRUITING

    Shanghai, 200031, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cochlear implantation (surgical procedure)

What this could lead to

If successful, this could help tailor hearing and speech rehabilitation for different age groups, improving outcomes after cochlear implants.

What could go wrong

This is an observational follow-up study, not a test of a new treatment. Results may not lead to immediate changes in care, and individual outcomes vary widely.

Conditions

The condition(s) this trial relates to.

Deafness hearing loss disorder Hearing Loss, Sensorineural

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.